Holistic Needs Assessment in Outpatient Cancer Care
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02274701|
Recruitment Status : Unknown
Verified October 2014 by Jenny Young, University of the West of Scotland.
Recruitment status was: Not yet recruiting
First Posted : October 24, 2014
Last Update Posted : October 27, 2014
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
|Condition or disease||Intervention/treatment||Phase|
|Oncology [See Also, Affected System]||Other: Holistic Needs Assessment||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||156 participants|
|Intervention Model:||Parallel Assignment|
|Primary Purpose:||Supportive Care|
|Official Title:||Evaluating the Impact of Holistic Needs Assessment in Outpatient Cancer Care|
|Study Start Date :||October 2014|
|Estimated Primary Completion Date :||October 2015|
|Estimated Study Completion Date :||February 2016|
Experimental: Holistic Needs Assessment
Participants (patients) complete a self-reported paper assessment that asks them to indicate whether they have any emotional, practical, financial and/or clinical concerns. The patient then takes this completed assessment into their consultation. It is then given to the clinician where it informs a discussion based on the patient's needs and concerns as identified by them. A care plan is then written based on this assessment.
Other: Holistic Needs Assessment
An assessment completed by the patient in cancer care. It is recommended that this assessment is completed at key points in the care pathway, such as at diagnosis, post treatment and beginning of end of life care. The aim of this assessment is to allow the patient to discuss their most important needs as identified by them. The clinician will take any appropriate action. This may range from listening to the patient to referring to another member of the multi-disciplinary team.
Other Name: The Concerns Checklist
No Intervention: Control
The control group entails standard care - routine consultation between the patient and clinician.
- Patient participation [ Time Frame: This outcome measure will be collected during the patients first clinic appointment after treatment for their cancer. The consultation will last approximately 15 minutes. ]Measured through analysis of the audio-recordings from each recorded consultation between a clinician and patient. Specifically, through measuring dialogue ratio and preponderance of initiative. These two measures indicate who is speaking, when and for how long.
- Shared decision making [ Time Frame: This outcome measure will be collected following the patients first clinic appointment after treatment. The patient will return to the researcher and complete this measure. It is expected to take no more than 1 minute to complete. ]Measured through patient self-report using the measure CollaboRATE. CollaboRATE is a survey-based validated tool designed to create a fast way to measure how much effort clinicians make to explain their patients' health issues; how much effort they make to listen to the issues that matter most to their patients and how much effort they make to integrate the patients' views and health beliefs.
- Self-efficacy [ Time Frame: This outcome measure will be collected following the patients first clinic appointment after treatment. The patient will return to the researcher and complete this measure. It is expected to take no more than 5 minutes.. ]Measured through self-report using The Lorig Self-Efficacy for Managing Chronic Disease 6-Item Scale.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||18 Years and older (Adult, Older Adult)|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||No|
- Over 18, capable of informed consent and expresses a wish to participate.
- Diagnosed with cancer and attending a post-treatment out-patient oncology clinic.
- Individuals not diagnosed with cancer.
- Non English speaker
- Person deemed incapable of consenting to participate as defined by the Adults with Incapacity Act (2000)
- Any reason which in the opinion of the clinician/investigator interferes with the ability of the patient to participate in the study
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02274701
|Contact: Austyn Snowden||Austyn.Snowden@uws.ac.uk|
|Contact: Jenny Young||01418494121||Jenny.Young@uws.ac.uk|
|Principal Investigator:||Austyn Snowden, PhD||University of the West of Scotland|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
|Responsible Party:||Jenny Young, Mrs Jenny Young, University of the West of Scotland|
|Other Study ID Numbers:||
|First Posted:||October 24, 2014 Key Record Dates|
|Last Update Posted:||October 27, 2014|
|Last Verified:||October 2014|